StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ONC

BeOne Medicines AG

ONC Nasdaq Pharmaceutical Preparations EDGAR ↗
$313.77
-8.31 -2.58%

Key statistics

from XBRL data in SEC filings
Market cap
$453B
Revenue (TTM)
$5.74B
Net income (TTM)
$513M
EPS (TTM)
$0.34
P/E ratio
922.9
Dividend yield
Free cash flow
$942M
Cash
$4.79B
Total assets
$8.55B
Gross margin
88.3%
52-week range
$253.95 – $385.22

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 26, 2026 8-K Director or officer change; Shareholder vote results Jun 11, 2026 8-K Other events May 15, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Results of operations (earnings release) Apr 14, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Terminated a material agreement Dec 19, 2025 8-K Director or officer change Dec 18, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Results of operations (earnings release) Aug 29, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results May 21, 2025 8-K Unregistered sale of equity May 13, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Other events Apr 29, 2025 8-K Shareholder vote results Apr 28, 2025 8-K Results of operations (earnings release) Apr 28, 2025 10-K/A Fiscal year ended 2024-12-31 Feb 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-K/A Fiscal year ended 2023-12-31 Jan 8, 2025 8-K Other events Dec 23, 2024 8-K Entered a material agreement; Took on a direct financial obligation Dec 10, 2024 8-K Other events Nov 19, 2024 8-K Other events Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Other events Nov 12, 2024 8-K Other events Oct 28, 2024 8-K Other events Sep 30, 2024 8-K Director or officer change Sep 26, 2024 8-K Results of operations (earnings release) Aug 29, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024